IL-22 vs. IL-22: The Tissue Matters~!2009-08-25~!2009-11-04~!2010-07-14~!
The Open Autoimmunity Journal · 2010
DOI: 10.2174/1876894601002040181 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Autoimmunity Journal, 2010. Verfasst von Katharina Kreymborg. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
IL-22 is a cytokine recently discovered to be produced by TH17 cells. Its receptor is expressed in the skin, liver, the digestive and the respiratory tract where IL-22 conveys signals of the immune system directly to the tissue. IL-22 is involved in the host defense against extracellular pathogens as well as in autoimmune inflammatory diseases and exerts, depending on the tissue and inflammatory context, proinflammatory, protective or no evident function. Focusing on im- mune-mediated pathology, here we will discuss the role of IL-22 in the context of tissue inflammation to provide an over- view of the complex properties of this bi-functional cytokine and to disentangle some of its apparently aberrant actions.
Zitieren
APA
Kreymborg, K. (2010). IL-22 vs. IL-22: The Tissue Matters~!2009-08-25~!2009-11-04~!2010-07-14~!. The Open Autoimmunity Journal. https://doi.org/10.2174/1876894601002040181
Vancouver
Kreymborg K. IL-22 vs. IL-22: The Tissue Matters~!2009-08-25~!2009-11-04~!2010-07-14~!. The Open Autoimmunity Journal. 2010. doi:10.2174/1876894601002040181
BibTeX
@article{Kreymborg2010,
author = {Kreymborg, Katharina},
title = {IL-22 vs. IL-22: The Tissue Matters~!2009-08-25~!2009-11-04~!2010-07-14~!},
journal = {The Open Autoimmunity Journal},
year = {2010},
doi = {10.2174/1876894601002040181}
}
EUVIMED